Systems and methods for simulating cardiovascular fluid flow
Summary
USPTO granted patent US12594417B2 to Technologies Lifeengine Inc. for a system and methods simulating cardiovascular fluid flow with pulsatile flow and systemic resistance components. The system includes a reservoir, pump, input and output channels with valves, and a processor configured to control valves to generate target fluid flow profiles in test members. The patent contains 18 claims covering both systems and methods for cardiovascular flow simulation.
What changed
USPTO issued patent US12594417B2 titled 'Systems and methods for simulating cardiovascular fluid flow' to Technologies Lifeengine Inc. The patent covers a fluid flow simulation system with a reservoir, pump, input/output channels, first and second valves, and a processor configured to generate target pulsatile flow and target systemic pressure components in a test member. The filing date was June 13, 2022, under application number 18569031.
For medical device manufacturers developing cardiovascular devices, this patent establishes IP rights that may require licensing or design-around strategies. Companies engaged in hemodynamic testing, cardiovascular simulation, or pulsatile flow systems should assess whether their products fall within the scope of the 18 claims covering systems and methods for cardiovascular fluid flow simulation with controlled pulsatile and resistance components.
What to do next
- Monitor patent portfolio for potential infringement risks
- Evaluate licensing opportunities for cardiovascular simulation technology
- Review design alternatives if developing similar flow simulation systems
Archived snapshot
Apr 7, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
Systems and methods for simulating cardiovascular fluid flow
Grant US12594417B2 Kind: B2 Apr 07, 2026
Assignee
TECHNOLOGIES LIFEENGINE INC.
Inventors
Catherine Forest-Nault, Aymeric Guy, Guillaume Febrer
Abstract
A system for simulating cardiovascular fluid flow having a target fluid flow profile, which has target pulsatile flow and target systemic resistance components, in a test member is disclosed. The system includes a reservoir, a pump, input and output channels, a first valve in the input channel, a second valve in the output channel, and a processor. The input and output channels are connectable to the test member so as to form a fluid circuit with the test member. The processor is configured to execute a method for controlling the first valve to generate the target pulsatile flow component in the input channel, and controlling the second valve to generate the target systemic pressure component. Other systems are also disclosed. Methods for simulating target fluid flow profiles in a test member are also disclosed.
CPC Classifications
A61M 2205/3334 A61M 2210/125 A61M 60/851 G01F 1/72 G01F 25/10
Filing Date
2022-06-13
Application No.
18569031
Claims
18
Related changes
Get daily alerts for ChangeBridge: Patent Grants - Medical Devices (A61M)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The plain-English summary, classification, and "what to do next" steps are AI-generated from the original text. Cite the source document, not the AI analysis.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when ChangeBridge: Patent Grants - Medical Devices (A61M) publishes new changes.